Covid-19 is associated with a wide range of symptoms and clinical trajectories, and early identification of patients at risk for developing severe disease is desirable. Several risk markers and comorbidity profiles have been proposed but their relative importance in unselected patients admitted to hospital with Covid-19 remains unclear. This study aims to assess the prognostic value organ specific biomarkers, viral dynamics and immune response markers in patients infected with SARS-CoV2.
Inclusion Criteria:
- All patients >18 years of age with a positive test for SARS-CoV2 are eligble for
inclusion.
- Healty age-matched volunteers will be included as a control group
Exclusion Criteria:
- None
Akershus University Hospital
Lørenskog, Norway
Investigator: Peder Myhre, MD, PhD
Contact: 6790000
p.l.myhre@medisin.uio.no
Torbjørn Omland, MD, PhD
67960000
torbjorn.omland@medisin.uio.no